News/Update FDA March 24, 2026

Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Magnesium Sulfate in Water for Injection, USP 4 g/100mL (NDC 70121-1720-3) Due to a Product Mix-up with Tranexamic Acid in 0.7% Sodium Chloride Injection, 10 mg/mL

Bridgewater, New Jersey, Amneal Pharmaceuticals LLC is voluntarily recalling one lot of Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, to the hospital level. A Magnesium Sulfate in...

Want the full context? Use Regulator to track the source, deadlines, and weekly briefing.
Document type: News/Update. Agency: FDA. Published: 2026-03-24.

Why this matters to food and beverage teams

This news update is worth screening if your team tracks fda activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.

The practical question is whether this changes food safety and label-control exposure. If it does, pull the source document and decide whether the item needs action now, monitoring, or no response.

View original source document

Need the operator impact, not just the source document?

Get a custom Regulator Weekly Action Brief with the deadlines, business impact, and next actions that matter to your facility or product line. Your first custom brief is free.